First domestic innovative weight-loss drug approved in China

16 August 2023
obesity_weight_big

According to the official website of the China State Drug Administration the application for marketing authorization of Feisumei (benaglutide) injection for obesity or overweight indications declared by Benemae Pharmaceuticals/Renhui Biotech was approved for weight management of adults.

The first original new drug approved for weight loss indications in China, and the third GLP-1 weight loss drug approved globally after Danish diabetes care giant Novo Nordisk's (NOV: N) developed liraglutide and semaglutide drugs bring new treatment options for overweight and obese patients.

Benaglutide is a fully human GLP-1 receptor agonist independently developed by Renhui Biotechnology. Its amino acid sequence is 100% identical to the human natural GLP-1. It is characterized by a low incidence of antibodies, significant curative effect, and better safety.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical